Doc #126 — Medical Device Maintenance: Triage, Life Extension, and Technician Training

---

RECOMMENDED ACTIONS

Phase 1 — First month

1. Include medical devices in the national asset census (Doc #8). Every hospital, primary care practice, dental surgery, veterinary clinic, and private radiology practice reports all significant medical equipment: type, manufacturer, model, serial number, age, condition, consumable dependencies, and last service date. [URGENT — information-gathering, not action]
2. Identify and register all biomedical equipment technicians. NZ has a small workforce of biomedical technicians and engineers — estimated at 200–400 nationally.² These individuals are critical-skills personnel (Doc #126). They must be identified, retained, and protected from reallocation to other trades.
3. Secure spare parts and consumable stocks. Medical device distributors and service companies (Fisher & Paykel Healthcare, Draeger, GE HealthCare, Philips, Siemens Healthineers — all have NZ service operations or distributors) hold in-country stocks of spare parts and consumables. These stocks are requisitioned under the national stockpile framework (Doc #1, Category A) and centrally allocated. [URGENT — stocks are modest and at risk of informal dispersal]
4. Issue device preservation guidance. For devices that will not be used immediately (elective imaging, non-essential diagnostics), issue shutdown and storage protocols to prevent degradation from disuse. Powered-down electronics stored in dry, temperature-stable environments last longer than equipment left running or exposed to power fluctuations.

Phase 1–2 — First year

5. Classify all medical devices into triage categories (Section 3). Category 1 devices are maintained at all costs; Category 2 devices are maintained while parts and consumables last; Category 3 devices are cannibalised for parts; Category 4 devices are abandoned. [HIGH PRIORITY — this framework guides all subsequent maintenance decisions]
6. Consolidate imaging equipment. Reduce the number of operational CT, X-ray, and ultrasound units to the minimum needed for essential clinical care. Concentrate these in regional centres with the best maintenance support and most reliable power. Decommission surplus units as parts donors.
7. Begin biomedical technician training programme (Section 8). Expand the biomedical technician workforce from 200–400 to approximately 500–800 over 2–3 years. Recruit from existing electricians, electronics technicians, and mechanical fitters — people who already have adjacent skills.
8. Establish autoclave maintenance as the single highest device priority (Section 4). Without sterilisation, surgical wound infection rates return to pre-antiseptic levels (30–60% for major operations — see Section 4). Every hospital and surgical facility must have functioning sterilisation, and the supply chain for autoclave parts must be secured for decades.

Phase 2–3 — Years 1–5

9. Progressive cannibalisation of Category 3 devices to sustain Category 1 and 2 equipment. Record every part stripped, from what unit, in what condition, and where it is stored. (Integrates with Doc #88 spare parts triage framework.)
10. Develop local fabrication capability for autoclave and steriliser components: gaskets, heating elements, pressure relief valves, temperature sensors. Machine shops (Doc #88) and electrical workshops begin producing these as standard items.
11. Transition from electronic to mechanical laboratory instruments where possible. Manual microscopes replace automated systems. Hand-cranked centrifuges supplement or replace electric units. Mechanical sphygmomanometers replace electronic blood pressure monitors.
12. X-ray tube conservation programme (Section 5). Extend tube life through reduced-exposure protocols, optimal technique, and tube rotation between units.

Phase 3+ — Years 5 onward

13. Assess the surviving fleet. By Phase 3, the medical device landscape is fundamentally different from pre-event. Some categories (autoclaves, microscopes, basic centrifuges) should be fully maintainable. Others (X-ray, ultrasound) are degraded but partially functional. Others (CT, MRI) are gone. Plan healthcare delivery around what remains.

---

ECONOMIC JUSTIFICATION

What is being preserved

NZ’s pre-event medical device fleet has an estimated replacement value of several billion dollars.³ That figure is meaningless under recovery conditions. What matters is functional value: a working autoclave means surgery can happen. A working X-ray machine means fractures and pneumonias are diagnosed rather than guessed at. A working ventilator means a patient with respiratory failure can be supported through the acute phase rather than managed with positional and supportive measures alone.

The cost of a maintenance programme

Biomedical technician workforce: Expanding from approximately 200–400 to approximately 500–800 technicians over 3 years requires approximately 200–500 person-years of training (depending on starting workforce size and the proportion of recruits with strong adjacent skills, which reduces training duration) and approximately 500–800 person-years per year of ongoing labour at steady state. This is a significant but manageable investment — comparable to maintaining 2–3 medium-sized workshops (Doc #91).

Parts fabrication: Machine shop time for autoclave components, gaskets, heating elements, and other locally producible parts: estimated at 20–50 person-years per year across all NZ facilities. This draws on existing metalworking and electrical skills.

These two cost components differ sharply in scarcity. The 200–500 person-years of technician training requires specialist educators with biomedical engineering knowledge — a genuinely scarce resource with no ready substitutes. The parts fabrication labour, by contrast, draws on general metalworking and electrical skills that are more widely available in the recovery workforce and competes less with other critical programmes for the same personnel.

Total programme cost: Approximately 550–850 person-years per year at steady state (range reflects uncertainty in workforce size and fabrication demand) — roughly 0.02–0.03% of NZ’s working-age population. This is the cost of maintaining surgical capability, diagnostic imaging, and laboratory medicine. The alternative is not “saving those person-years for other work.” The alternative is healthcare without sterilisation, without imaging, without laboratory diagnosis — a regression that would cost far more in lives and productive capacity than the maintenance programme consumes.

Comparison: maintaining vs. abandoning

Capability	With maintenance programme	Without maintenance programme
Surgery	Continues with autoclave sterilisation	Wound infection rates return to 30–60% within 1–3 years as sterilisation fails
Fracture diagnosis	X-ray available at regional centres for 5–15 years	Clinical assessment only — significant misdiagnosis rate
Blood analysis	Basic cell counts and chemistry available	No objective blood data — clinical decisions based on symptoms alone
Obstetric care	Ultrasound available for high-risk pregnancies for 5–15 years	No prenatal imaging — higher maternal and neonatal mortality
Pneumonia diagnosis	X-ray differentiation of bacterial vs. viral, effusion detection	Clinical assessment only — inappropriate antibiotic use increases

The breakeven is immediate. The maintenance programme costs person-years; its absence costs lives.

---

3. DEVICE TRIAGE FRAMEWORK

3.1 Triage categories

Every medical device in NZ is classified into one of four categories based on two factors: clinical value under recovery conditions and maintainability with NZ resources.

Category 1 — Maintain at all costs

These devices are both clinically essential and maintainable indefinitely using NZ skills and materials.

Device type	Why essential	Why maintainable
Autoclaves (steam sterilisers)	Without sterilisation, surgical wound infection rates return to 30–60% for major operations4	Pressure vessels with replaceable gaskets, heating elements, valves, and gauges. All components fabricable locally
Microscopes (optical, manual)	Essential for pathology, microbiology, parasitology, haematology	No consumables beyond glass slides and immersion oil. Mechanical and optical — no electronics required for basic models
Manual centrifuges	Blood separation for basic haematology, urinalysis, biochemistry	Mechanical device. Bearings and housing can be maintained by machine shops
Mechanical sphygmomanometers	Blood pressure measurement — foundational vital sign	Mercury or aneroid mechanisms. No electronics. Mercury supply is finite but NZ has existing stock
Surgical instruments (reusable)	Required for all surgical procedures	Metal instruments cleaned and resterilised indefinitely. Sharpening and minor repair at machine shops
Stethoscopes	Auscultation for cardiac, respiratory, and abdominal assessment	No consumables. Rubber tubing is the wear component — replaceable from NZ rubber stocks or improvised materials

Category 2 — Maintain while consumables and parts last; extend aggressively

These devices are clinically valuable but depend on components NZ cannot fabricate. Their lifespan is finite but can be extended significantly through conservation.

Device type	Limiting factor	Estimated NZ lifespan with conservation
X-ray machines (conventional)	X-ray tubes — finite life, irreplaceable.5 Tube life depends on usage: 50,000–200,000 exposures depending on type and technique	5–15 years with aggressive tube conservation and cannibalisation from decommissioned units
Ultrasound machines	Transducer piezoelectric elements degrade; electronic boards fail. Solid-state design means fewer mechanical failure modes6	5–20 years depending on model, usage intensity, and availability of cannibalised replacement boards
Ventilators and anaesthesia machines	Electronic control boards, flow sensors, oxygen sensors, pressure transducers. Mechanical components (bellows, valves) are more maintainable7	5–15 years with parts cannibalisation. Mechanical ventilators and draw-over anaesthesia systems last longer than electronic models
Electric centrifuges (high-speed)	Bearings, motors, electronic speed controllers	5–15 years with bearing replacement from cannibalised units
Defibrillators	Batteries (finite charge cycles), capacitors, electronic boards	3–10 years depending on battery availability and usage
Pulse oximeters	LED/photodetector sensors, batteries, electronic processing	3–10 years. Disposable finger sensors are the binding consumable
Patient monitors	Electronic components, display screens, sensor cables	5–10 years with cannibalised parts
Infusion pumps	Electronic boards, motor drives, disposable tubing sets	3–10 years. Gravity infusion is the fallback
Dental drills (electric/pneumatic)	Bearings, burs (tungsten carbide — not locally producible), turbine cartridges	5–15 years with parts cannibalisation. Hand instruments are the fallback
Electrocardiographs (ECGs)	Electronic boards, thermal print heads, ECG electrode gel	5–15 years. Electrode gel can be improvised from saline-soaked pads for basic tracings, though signal quality degrades (increased baseline wander and motion artefact compared to commercial gel electrodes)

Category 3 — Cannibalise for parts

Devices that are either clinically marginal under recovery conditions or functionally identical to other units that have been designated for continued use. These are systematically stripped for parts to sustain Category 1 and 2 equipment.

Examples: Surplus imaging units beyond the minimum operational fleet. Non-essential patient monitors. Specialised laboratory analysers that duplicate capability available from simpler equipment. Consumer-grade medical electronics.

Category 4 — Abandon

Devices that are both unmaintainable and functionally irreplaceable. Attempting to maintain these wastes technician time and parts that could sustain more durable equipment.

Device type	Why abandon
MRI scanners	Superconducting magnets require liquid helium (NZ has no production) and cryocooler maintenance.8 When helium boils off, the magnet quenches irreversibly. Gradient amplifiers and RF systems are highly specialised electronics. Software requires vendor-specific hardware. Estimated time to failure: 1–5 years without helium resupply
CT scanners	Rotating X-ray tube assemblies with extremely high thermal demands and precision bearings. Tube replacement requires exact manufacturer match. Electronic reconstruction systems are proprietary and complex.9 Estimated lifespan: 1–5 years, less if used intensively
PET/SPECT scanners	Require radioactive isotopes (produced in cyclotrons or nuclear reactors — neither available in NZ post-event) and specialised detector arrays
Linear accelerators (radiotherapy)	Require precise electronic control, specialised high-voltage components, and regular calibration with dosimetry equipment that depends on imported standards
Automated chemistry analysers (high-throughput)	Depend on proprietary reagent cartridges imported from the manufacturer. When cartridges are exhausted, the analyser is an expensive box10

3.2 The hard truth about imaging

NZ currently has approximately 40–50 CT scanners, 10–15 MRI scanners, and several hundred conventional X-ray units across public hospitals, private radiology practices, and ACC-funded facilities.¹¹ Under this triage framework:

• MRI: All units will become non-functional within 1–5 years. There is no mitigation strategy. Clinical pathways that currently depend on MRI (soft tissue diagnosis, neurological assessment, musculoskeletal imaging) must develop alternatives — primarily ultrasound for soft tissue where ultrasound is applicable, and clinical assessment where it is not.
• CT: All units will fail within 1–5 years. CT tubes are specialised, high-power X-ray tubes with rotating anodes that operate under extreme thermal stress. They cannot be fabricated locally and cannot be substituted from conventional X-ray tube stock.¹² CT’s clinical role (trauma assessment, cancer staging, vascular imaging) shifts to conventional X-ray, ultrasound, and clinical judgement.
• Conventional X-ray: The last imaging modality standing. With aggressive tube conservation, cannibalisation, and reduced utilisation, conventional X-ray can persist for 5–15 years at reduced capacity. This is the imaging capability NZ must protect.
• Ultrasound: Potentially long-lived because it is solid-state with no high-wear consumables comparable to X-ray tubes.¹³ Electronic failures are the primary threat. With cannibalised electronic boards and careful maintenance, some ultrasound units could function for 10–20 years.

3.3 Consolidation strategy

Operating fewer units more carefully extends the fleet’s aggregate lifespan. The consolidation strategy:

1. Designate imaging centres. Reduce the number of sites operating X-ray and ultrasound from hundreds to approximately 20–30 — one or two per health district, located at the major public hospitals. Each centre receives the best-condition equipment, the most reliable power supply, and dedicated biomedical technician support.
2. Decommission surplus sites. Private radiology practices, small rural hospitals, and dental practices with X-ray capability surrender their units. These become the cannibalisation pool.
3. Clinical referral pathways. Patients requiring imaging travel to the designated centre. This is inconvenient and creates transport costs, but it concentrates scarce technician expertise and extends equipment life. Mobile X-ray units could serve rural populations on a circuit, if vehicle transport (Doc #6) and fuel allocation (Doc #53) support it.

---

4. AUTOCLAVE MAINTENANCE: THE SINGLE HIGHEST PRIORITY

4.1 Why autoclaves matter more than anything else in this document

Surgery without sterilisation carries infection rates that make most major procedures unjustifiable on a risk-benefit basis. Before reliable sterilisation, surgical wound infection rates ranged from 30–60% for major operations, with corresponding mortality.¹⁴ The difference between pre-antiseptic surgery and modern surgery is not primarily surgical technique — it is sterilisation. Maintaining autoclave function is therefore a precondition for maintaining surgical capability.

NZ’s hospital system operates several hundred autoclaves of various sizes, from large pass-through sterilisers in central sterile services departments (CSSDs) to small benchtop units in dental practices and GP clinics.¹⁵ The installed fleet is a mix of ages, manufacturers, and technologies — predominantly from Getinge, Steris, Belimed, and Tuttnauer, with some locally distributed brands.

4.2 How an autoclave works

A steam steriliser is functionally a pressure cooker. It heats water to produce steam, raises the chamber pressure to 1.0–1.4 bar above atmospheric (allowing temperatures of 121–134°C), holds the load at that temperature for a defined period (typically 3–15 minutes at 134°C or 15–30 minutes at 121°C), and then exhausts the steam and dries the load.¹⁶

The core components:

Component	Function	Failure mode	Local fabrication potential
Pressure vessel (chamber)	Contains the steam under pressure	Corrosion, cracking (rare — vessels are designed for decades of service)	NZ can fabricate pressure vessels. NZ Steel (Doc #89) produces suitable steel. Welding capability exists (Doc #89). Pressure testing per AS/NZS standards requires a test pump — available in NZ
Door gasket	Seals the chamber door	Degrades with heat cycling. Replacement interval: 6–24 months depending on material and usage17	Silicone or EPDM rubber gaskets. NZ does not produce silicone or EPDM, but existing stocks of these materials exist in NZ’s industrial supply chain. When stocks are exhausted: natural rubber (if available from trade, Doc #33) or fabricated gaskets from alternative elastomers. This is a real constraint
Heating element	Heats water to produce steam	Burns out over time. Nichrome wire resistance elements — NZ can wind replacement elements if nichrome wire is available from cannibalised sources	Nichrome wire from cannibalised heating appliances (ovens, toasters, industrial heaters) is abundant in NZ. Rewinding heating elements is within NZ’s electrical workshop capability
Steam generator (for units with external generators)	Produces steam externally	Boiler maintenance — descaling, tube inspection, safety valve testing	Boiler maintenance is an existing NZ trade skill. Industrial boiler technicians are available (Doc #8)
Temperature sensor and controller	Monitors and controls sterilisation temperature	Electronic controller failure; sensor drift	Electronic controllers can be cannibalised from decommissioned units. Temperature sensors (thermocouples, RTDs) are standard industrial components — available from NZ’s industrial supply chain for years. Longer term: mercury thermometers and manual control are feasible but require operator training
Pressure gauge	Monitors chamber pressure	Mechanical gauge failure (rare); electronic transducer failure	Mechanical Bourdon tube pressure gauges are robust and available from NZ’s industrial supply chain (used widely in dairy, process, and water industries). These can be serviced and recalibrated by instrument technicians
Safety valve (pressure relief)	Prevents over-pressurisation	Spring fatigue, seat corrosion	Standard industrial safety valves. NZ can service and test these. Machine shops can fabricate replacement valve seats
Vacuum pump (for pre-vacuum cycles)	Removes air from the chamber before sterilisation	Motor failure, seal failure, vane wear	Electric motors are repairable. Pump seals and vanes wear — cannibalise from decommissioned units. Gravity-displacement cycles (no vacuum pump) are an alternative with longer cycle times
Water treatment (deionisers, filters)	Provides clean water to prevent mineral deposits	Filter and resin exhaustion	Rainwater collection provides low-mineral water in most NZ regions. Distillation (feasible with NZ energy) is the long-term alternative to imported deioniser resins

4.3 Maintenance programme

Routine maintenance (biomedical technician, monthly to quarterly):

• Inspect and clean door gaskets. Replace when cracked, deformed, or leaking.
• Test safety valve function. Document set pressure and reseat condition.
• Descale chamber and steam generator. NZ water varies in hardness by region — South Island west coast and central North Island have softer water; Canterbury and Hawke’s Bay are harder.¹⁸ Descale frequency depends on local water quality.
• Test temperature accuracy with calibrated reference thermometer.
• Inspect and test biological indicators (spore tests) — the definitive test of sterilisation efficacy. Bacillus stearothermophilus spore strips are imported and finite. When exhausted, chemical indicators (colour-change tapes and strips) provide partial verification, and regular thermocouple validation of cycle temperatures provides a physics-based substitute.¹⁹
• Inspect electrical connections, heating elements, and controls.

Major maintenance (annually or as needed):

• Gasket replacement.
• Heating element inspection and replacement if resistance has changed significantly.
• Pressure vessel inspection per applicable pressure vessel standards (AS/NZS 3788 or equivalent). This is an existing NZ regulatory and trade competency — pressure vessel inspectors exist in NZ’s industrial sector.
• Vacuum pump overhaul (if applicable).
• Controller calibration or replacement.

4.4 The gasket problem

Autoclave door gaskets are the single most consumed wear part. They are made from silicone or EPDM (ethylene propylene diene monomer) rubber — both of which are synthetic polymers that NZ does not produce. Existing NZ stocks of silicone and EPDM rubber in industrial supply chains (seals, gaskets, O-rings across many industries) represent a finite reserve that must be managed under the spare parts triage framework (Doc #88).

Estimated gasket stock: NZ’s industrial supply chain holds gasket material for a wide range of applications — hydraulic seals, process piping, food processing equipment, and general industrial use. The total stock of silicone and EPDM material is unknown but likely measured in tens of tonnes across all distributors and end-users.²⁰ Autoclave gaskets are a tiny fraction of total demand for elastomer seals, but they are among the highest-priority uses.

Mitigation: - Prioritise high-grade elastomer stock for autoclave and medical equipment gaskets. - Reduce gasket wear by operating autoclaves at conservative temperatures where clinically acceptable (121°C rather than 134°C extends gasket life, at the cost of longer cycle times). - Investigate alternative gasket materials: natural rubber (inferior heat resistance — limited to ~100°C, insufficient for standard autoclave cycles), PTFE (Teflon — NZ has existing stock, excellent temperature resistance but poor resilience as a compression seal), cork-rubber composites (limited temperature tolerance). - The honest assessment: when synthetic elastomer stocks are exhausted, autoclave gasket fabrication from locally available materials is a genuine engineering challenge rated [C] Difficult. This is a problem that needs active research beginning in Phase 1.

4.5 Fallback sterilisation methods

If autoclave capacity is insufficient, fallback methods exist but with significant limitations:

• Boiling: 100°C for 20–30 minutes kills vegetative bacteria but does not reliably kill bacterial spores. Acceptable for instruments used in minor procedures; insufficient for major surgery.²¹
• Dry heat sterilisation (oven): 160–170°C for 1–2 hours. Effective but damages many materials and instruments. Requires only an oven with reliable temperature control — fabricable from NZ materials. Appropriate for metal instruments, glass, and some other heat-resistant items.
• Chemical sterilisation (glutaraldehyde, peracetic acid, ethylene oxide): Effective but dependent on imported chemicals. Glutaraldehyde stocks in NZ are finite. Ethylene oxide is a carcinogenic gas requiring specialised equipment. Peracetic acid can be produced from acetic acid and hydrogen peroxide — both potentially producible in NZ (acetic acid from fermentation is [A] feasible; hydrogen peroxide requires either the anthraquinone process or electrochemical production, rated [C] Difficult), making this a candidate for longer-term local production.²²
• Alcohol and iodine disinfection: Not sterilisation — reduces microbial load but does not achieve sterility. Acceptable for skin preparation and surface disinfection, not for instrument sterilisation.

---

5. IMAGING EQUIPMENT LIFE EXTENSION

5.1 X-ray tube conservation

An X-ray tube is a vacuum tube containing a cathode (electron source) and an anode (target, usually tungsten or tungsten-rhenium alloy). Electrons accelerated from cathode to anode produce X-rays when they strike the target. The anode degrades with use — the focal spot roughens, target material evaporates, and bearing lubrication in rotating-anode tubes degrades. Eventually the tube fails: filament burns out, anode cracks from thermal stress, vacuum seal leaks, or bearings seize.²³

Tube life depends on usage intensity: A diagnostic X-ray tube in a busy hospital might produce 50,000–200,000 exposures over its lifetime, depending on tube type and technique. Reducing the number of exposures directly extends tube life.

Conservation protocols:

1. Strict clinical indication. Every X-ray exposure must have a clinical justification documented by the requesting clinician. No routine screening, no “just in case” films, no repeat exposures for image quality that is clinically adequate even if technically imperfect.
2. Optimal technique. Correct kVp, mAs, and collimation on first exposure to minimise repeat rates. Technique charts for common examinations posted at every unit. This requires trained radiographers — an existing NZ workforce of approximately 2,000–3,000.²⁴
3. Tube warm-up protocols. Proper warm-up sequences reduce thermal shock to the anode and extend tube life. Published by tube manufacturers and implementable by radiology departments.
4. Reduced workload per tube. Spreading exposures across multiple tubes (where multiple units exist at a facility) distributes wear.
5. Tube rotation. When a tube approaches end of life, it can be replaced with a cannibalised tube from a decommissioned unit. The national X-ray tube inventory — established through the asset census — determines how many spare tubes exist.

Estimated X-ray fleet lifespan: NZ has several hundred X-ray units.²⁵ If the operational fleet is reduced to 30–50 units at designated imaging centres, and spare tubes from decommissioned units provide a replacement pool of perhaps 200–500 additional tubes, the aggregate lifespan of NZ’s X-ray capability could extend to 10–20 years under conservative usage. This is an estimate with wide uncertainty — actual lifespan depends on tube condition, usage rates, and the success of conservation measures.

5.2 Ultrasound: the longest-lived imaging modality

Ultrasound has significant advantages for long-term survivability:

• No high-wear consumables comparable to X-ray tubes. The piezoelectric transducer elements degrade slowly over years of use.²⁶
• Solid-state electronics with no moving parts in the main unit (though some transducers have mechanical scanning elements).
• Lower power consumption than X-ray or CT — can operate on modest generator or solar power if grid power is unavailable.
• Wide clinical utility: obstetric imaging, abdominal assessment, cardiac evaluation (echocardiography), vascular assessment, musculoskeletal imaging, procedural guidance (line placement, biopsies).

Vulnerabilities: - Transducer cable failure — cables flex repeatedly and conductors eventually break. Repairable by skilled electronics technicians. - Electronic board failure — the primary long-term failure mode. Boards can be cannibalised from decommissioned units of the same model. - Display failure — LCD screens have finite backlite life and are vulnerable to electronic failure. CRT-based units (older models) are more repairable. - Gel supply — ultrasound requires acoustic coupling gel between transducer and skin. Commercial gel is imported. Substitutes include glycerin-water mixtures (glycerin is a byproduct of NZ’s tallow soap production — Doc #33), harakeke (flax) mucilage, and other water-based gels producible from NZ materials. These substitutes provide adequate acoustic coupling but may introduce more air micro-bubbles than commercial gel, slightly degrading image quality in superficial structures.²⁷

Strategy: Ultrasound should be prioritised as NZ’s long-term diagnostic imaging backbone. Protect ultrasound units, stockpile spare transducers and electronic boards through cannibalisation, and train ultrasonographers aggressively (Section 8).

5.3 Portable and battery-operated devices

Portable ultrasound units, handheld X-ray devices, and battery-operated point-of-care devices have an advantage: they are less dependent on facility infrastructure and can serve rural or mobile clinical needs. However, they depend on batteries — lithium-ion batteries have a finite number of charge cycles (typically 300–1,000 full cycles) and degrade even in storage.²⁸

Battery strategy: Centralise lithium-ion battery stocks from consumer electronics, laptop computers, and power tools. NZ’s population of approximately 5 million holds an estimated 5–10 million lithium-ion battery packs across personal devices, tools, and vehicles — a substantial reserve if systematically harvested.²⁹ Repurpose cells from these sources to refurbish medical device battery packs. This requires electronics technicians with battery management system (BMS) expertise — a training need that should be incorporated into the biomedical technician programme. Cell matching (selecting cells with similar capacity and internal resistance) is essential for safe repurposed packs; mismatched cells create fire risk and accelerated degradation.

---

6. LABORATORY EQUIPMENT

6.1 Microscopy

The optical microscope is perhaps the most durable and irreplaceable diagnostic instrument in medicine. A well-maintained microscope can function for 50–100 years. NZ’s hospitals and laboratories hold thousands of microscopes — clinical, teaching, and research — ranging from basic student models to advanced research instruments.³⁰

What microscopy provides under recovery conditions: - Haematology: manual differential white cell counts, platelet estimation, red cell morphology - Microbiology: Gram stain, acid-fast bacilli (TB diagnosis), wet preparations for parasites and fungi - Pathology: histological diagnosis from biopsied tissue - Parasitology: stool and blood parasite identification - Urinalysis: microscopic examination of urine sediment

Consumable dependencies: - Glass slides and coverslips: imported, finite. NZ has glass production capability (Doc #98) but producing optical-quality flat glass for microscope slides is a precision task rated [C] Difficult. Slides can be cleaned and reused multiple times. - Staining reagents (Gram stain, Wright-Giemsa, Ziehl-Neelsen, haematoxylin and eosin): imported chemical compounds. Some are producible from NZ materials — crystal violet from coal tar chemistry, iodine from seaweed (NZ has extensive kelp beds), safranin from coal tar. Others require more complex organic chemistry. Reagent stocks should be rationed and preserved.³¹ - Immersion oil: cedar oil or synthetic immersion oil. Cedar oil is producible from NZ native timbers, though quality may vary. Synthetic immersion oil stocks are finite.

Maintenance: Keep optics clean (lens tissue, not cloth). Store in dust-free, humidity-controlled environments. Mechanical stage and focus mechanisms need occasional lubrication (light machine oil). Illumination: older microscopes use mirrors (no consumables); newer ones use LED or halogen bulbs. LED illumination is solid-state and long-lived. Halogen bulbs can be cannibalised from automotive and household sources.

6.2 Centrifuges

Centrifuges separate blood and other fluids by density — essential for basic haematology (haematocrit, buffy coat analysis), biochemistry (serum preparation), and blood banking (component separation).

Types in NZ: - High-speed electric centrifuges: standard in all hospitals. Depend on electric motors, bearings, and electronic speed controllers. - Microhaematocrit centrifuges: small, high-speed units used for haematocrit determination. Mechanically straightforward (motor, rotor, lid interlock) and relatively durable. - Hand-cranked centrifuges: exist in field medicine and veterinary practice. No electrical components. Adequate for basic separations.

Life extension: Electric centrifuge motors and bearings are standard industrial components. Motor rewinding is an existing NZ trade skill. Bearings are available from NZ’s industrial bearing supply chain (Doc #95) and can be cannibalised from other rotating equipment. Electronic speed controllers are more vulnerable — cannibalise from identical models or retrofit with simpler mechanical speed control.

Fallback: Hand-cranked centrifuges are fabricable from NZ materials — a machined rotor, bearing assembly, and hand crank. Fabrication requires a lathe for the rotor (balanced to within 0.1 mm to prevent vibration), precision bearings (available from NZ industrial stocks or cannibalised sources), and a housing — within the capability of machine shops (Doc #91). Performance is significantly inferior to electric centrifuges: hand-cranked units typically achieve 2,000–3,000 g versus 5,000–15,000 g for clinical electric centrifuges, and sustained spin times are limited to 3–5 minutes by operator fatigue versus 10–15 minutes for electric units.³² This is adequate for haematocrit determination and basic serum separation but insufficient for applications requiring high g-force (e.g., platelet-poor plasma preparation, some microbiological concentration techniques).

6.3 Blood analysis

Modern hospital laboratories depend on automated analysers — haematology analysers (cell counters), chemistry analysers (electrolytes, liver function, renal function, glucose), blood gas analysers, and coagulation analysers. These are complex instruments running proprietary reagent cartridges and electronic systems. When reagent cartridges are exhausted, the analysers stop functioning regardless of their mechanical condition.³³

Transition plan: - Phase 1–2: Use automated analysers until reagent stocks are exhausted. Ration reagents by restricting which tests are run and how often. Prioritise: haemoglobin, blood glucose, electrolytes (sodium, potassium), renal function (creatinine), coagulation (INR for warfarin patients). - Phase 2–3: Transition to manual and semi-automated methods for essential tests: - Haemoglobin: Sahli method (acid haematin — requires hydrochloric acid, producible in NZ) or cyanmethaemoglobin method with manual spectrophotometry - Blood glucose: Benedict’s reagent (copper sulfate — requires copper and sulfuric acid, both available from NZ mining and chemical production; sodium carbonate — producible from soda ash or Leblanc/Solvay process; sodium citrate — requires citric acid, producible from fermentation). Local Benedict’s reagent production is rated [B] Feasible with investment, but concentration accuracy affects test reliability - Electrolytes: flame photometry for sodium and potassium (requires a flame photometer — some exist in NZ research laboratories) - Urinalysis: microscopy plus chemical reagent strips. Commercial dipstick strips are imported and finite; locally produced indicator papers (pH, protein, glucose) are feasible using established chemistry but with lower sensitivity and specificity than commercial multi-test strips - Coagulation: manual prothrombin time using thromboplastin and a water bath — established technique predating automated coagulation analysers

Spectrophotometers and colorimeters: These instruments are the backbone of manual clinical chemistry. They measure light absorption through a sample using a light source, wavelength selector (diffraction grating or prism), sample cuvette, photodetector, and readout electronics. The optical components are durable; the electronics (amplifier circuits, display) are the primary failure mode but are repairable at the component level by trained electronics technicians. Cuvettes are consumables — glass cuvettes can be cleaned and reused; plastic disposable cuvettes are finite. NZ universities and hospital laboratories hold an estimated several hundred spectrophotometers.³⁴ These should be classified as Category 1 (maintain at all costs) alongside microscopes and autoclaves.

---

7. VENTILATORS AND ANAESTHESIA MACHINES

7.1 Ventilators

NZ has an estimated 500–800 ventilators across ICU, emergency department, and anaesthetic settings — a number that expanded during the COVID-19 pandemic response.³⁵ Modern ventilators are microprocessor-controlled with electronic flow sensors, pressure transducers, oxygen sensors, and software-dependent operation.

Failure modes: - Oxygen sensor exhaustion (galvanic sensors have a finite lifespan — typically 1–3 years)³⁶ - Electronic board failure - Flow sensor degradation - Bellows and diaphragm wear (replaceable from cannibalised units) - Battery failure (for transport ventilators) - Software corruption (a real risk if storage media degrades)

Conservation strategy: - Reduce the operational ventilator fleet to the minimum needed for clinical demand. Many ventilators will be idle — mothball them properly as parts donors or future replacements. - Prioritise mechanically simpler models. Older ventilators with fewer electronic components and more mechanical controls are easier to maintain. The Manley ventilator (a gas-driven mechanical ventilator used widely in NZ historically) requires no electricity at all — any surviving units are extremely valuable.³⁷ - Fisher & Paykel Healthcare (Auckland) manufactures respiratory humidifiers, CPAP devices, and some respiratory products in NZ.³⁸ This is a rare instance of domestic medical device manufacturing. Fisher & Paykel’s NZ facilities, engineering staff, and institutional knowledge are a national strategic asset for respiratory equipment maintenance and potentially for manufacturing replacement components.

7.2 Anaesthesia machines

Anaesthesia is non-negotiable for surgery. Modern anaesthesia machines are complex systems delivering precise mixtures of oxygen, air, nitrous oxide, and volatile anaesthetic agents (sevoflurane, isoflurane, desflurane) through electronic vaporisers, ventilator circuits, and monitoring systems.

The vaporiser problem: Volatile anaesthetic agents are imported and finite. NZ stocks represent months to perhaps 1–2 years of normal surgical volume. When modern volatile agents are exhausted, the fallback is ether (diethyl ether) — producible from ethanol and sulfuric acid, both of which NZ can produce (ether synthesis rated [B] Feasible with investment — the chemistry is well-understood but requires careful temperature control and distillation to achieve anaesthetic-grade purity).³⁹ Ether anaesthesia is less safe than modern agents: it is flammable (requiring elimination of electrocautery and all ignition sources from the operating theatre), has a slower induction time (5–15 minutes versus 1–2 minutes for sevoflurane), produces more nausea and vomiting postoperatively, and has a narrower therapeutic window between surgical anaesthesia and respiratory depression.⁴⁰ It sustained surgery for over a century before modern agents replaced it, but the switch was driven by real clinical advantages — not fashion.

Draw-over anaesthesia: The draw-over technique — where the patient’s own breathing draws air through a vaporiser containing anaesthetic agent — requires no compressed gases, no electricity, and minimal equipment. Draw-over systems (such as the Epstein-Macintosh-Oxford or EMO vaporiser, the Triservice apparatus, and similar designs) are specifically designed for austere environments.⁴¹ NZ should identify any existing draw-over systems, and consider fabricating new ones. The core engineering — a calibrated evaporation chamber with temperature compensation — is within NZ’s metalworking capability, but calibration to deliver accurate agent concentrations requires testing against a reference analyser (agent concentration monitor), which is a finite imported resource. Feasibility: [B] for fabrication of the vaporiser body; [C] for calibration once reference analysers are exhausted.⁴²

Ketamine: A dissociative anaesthetic that can be administered intravenously or intramuscularly without complex equipment. Ketamine is stable, has a long shelf life (excellent SLEP extension potential), is already stocked in NZ hospitals, and is used in emergency and field medicine worldwide. Under rationing conditions, ketamine becomes the primary anaesthetic for short procedures and a supplement to volatile agents for longer operations.⁴³

---

8. BIOMEDICAL TECHNICIAN TRAINING

8.1 The current workforce

NZ’s biomedical engineering/technology workforce is small. The Institute of Biomedical Engineering and Technology (IBET NZ) represents biomedical engineers and technicians, and the workforce includes employees of hospitals (employed by Te Whatu Ora / Health NZ), private service companies, and medical device distributor service arms.⁴⁴

Estimate: 200–400 biomedical technicians and engineers nationally. This estimate is uncertain — no comprehensive workforce census exists in public sources. The national asset and skills census (Doc #8) must establish the actual number, location, and skill profile of these individuals.

This workforce is insufficient for the maintenance demands of a post-event healthcare system. Under normal conditions, much device maintenance is performed by manufacturer service engineers who fly in from Australia or overseas, or by distributor-employed technicians who rely on manufacturer technical support hotlines, online diagnostic tools, and shipped replacement parts. All of these support structures disappear when international links are severed.

8.2 Training programme

Target: Expand the biomedical technician workforce to approximately 500–800 within 3 years. This requires training approximately 200–400 new technicians — not from scratch, but from NZ’s existing pool of technically skilled tradespeople.

Recruitment pool: - Industrial electricians and electrical fitters: already understand electrical systems, circuit diagnosis, and safe working practices - Electronics technicians (from telecommunications, IT, broadcasting, military): already understand electronic circuit theory and component-level repair - Instrument technicians (from process industries — dairy, meat processing, chemical plants): already understand calibration, sensor systems, and control loops - Mechanical fitters and machinists: already understand precision assembly, bearing replacement, and mechanical systems

Training curriculum (12–18 months):

Module	Duration	Content	Prerequisites
Medical device safety and regulation	2 weeks	Electrical safety in clinical environments, IEC 60601 principles, infection control for technicians working in clinical areas, NZ regulatory framework	None — all trainees
Sterilisation equipment	4–6 weeks	Autoclave operation, maintenance, testing, gasket replacement, pressure vessel inspection, biological and chemical indicator interpretation	Electrical or mechanical background
Electromechanical medical devices	6–8 weeks	Centrifuges, suction units, surgical tables, dental chairs, infusion pumps — diagnosis, repair, parts fabrication	Mechanical or electrical background
Imaging equipment	8–12 weeks	X-ray generators, tube replacement, collimator adjustment, radiation safety, ultrasound transducer cable repair, image quality assessment	Electronics background strongly preferred
Respiratory and anaesthesia equipment	6–8 weeks	Ventilator maintenance, breathing circuit testing, vaporiser calibration, oxygen delivery systems, gas pipeline systems, Fisher & Paykel equipment	Electrical and mechanical background
Laboratory instruments	4–6 weeks	Microscope maintenance, centrifuge repair, spectrophotometer calibration, basic automated analyser troubleshooting	Electrical background
Electronics repair and cannibalisation	4–6 weeks	Component-level diagnosis and repair of medical device circuit boards, soldering, cable repair, battery management, systematic cannibalisation techniques	Electronics background

Training delivery: Hospital-based apprenticeship under existing biomedical technicians, supplemented by structured curriculum. The teaching hospitals — Auckland, Wellington, Christchurch, Dunedin, and Hamilton — are the natural training centres, as they hold the widest range of equipment and the most experienced technicians.

8.3 Institutional knowledge capture

NZ’s existing biomedical technicians hold irreplaceable knowledge about specific devices — service manuals memorised, failure modes diagnosed by sound or smell, repair techniques developed through years of hands-on experience. This knowledge must be captured before these individuals retire, die, or are otherwise lost. Documentation — written maintenance procedures, decision trees for common faults, parts substitution guides — should be produced and printed (Doc #5) as a priority. This is the medical device equivalent of heritage skills preservation (Doc #160).

---

CRITICAL UNCERTAINTIES

Uncertainty	Why it matters	How to resolve
Actual NZ medical device inventory	Triage requires knowing what exists, where, and in what condition	National asset census (Doc #8) — medical device module
Size and skill profile of biomedical technician workforce	Determines training gap and current maintenance capacity	Skills census (Doc #8)
In-country spare parts and consumable stocks	Determines how long Category 2 devices can be sustained	Inventory of medical device distributor service stocks (Doc #1 requisition)
Autoclave gasket material alternatives	Gaskets are the binding constraint on long-term sterilisation capability	Active research programme beginning Phase 1 — materials science and engineering challenge
X-ray tube remaining life in NZ fleet	Tube age and usage history determine how many exposures remain in the national fleet	Asset census + review of tube usage logs (most X-ray systems log cumulative exposure data)
Helium availability for MRI	Any helium supply extends MRI lifespan	NZ has no helium production. Import from Australia (if trade develops) is possible but helium is a specialised industrial gas — not a likely early trade commodity
Ultrasound transducer degradation rate	Determines how long ultrasound imaging remains available	Monitor transducer performance over time; limited published data on very-long-term degradation
Fisher & Paykel Healthcare capability	Their NZ manufacturing facility and engineering staff could be pivotal for respiratory equipment	Direct assessment of facility, staff, and manufacturing capability within the first month
Ether production feasibility from NZ materials	Fallback anaesthetic agent for when modern volatiles are exhausted	Chemical production trial using NZ-produced ethanol and sulfuric acid (Doc #113)
Biological indicator (spore test) stocks	Definitive sterilisation verification depends on these imported consumables	Inventory existing stocks; assess feasibility of local Bacillus stearothermophilus culture and spore strip production (requires microbiology laboratory capability)

---

CROSS-REFERENCES

Document	Relationship
Doc #1 — National Emergency Stockpile Strategy	Medical device spare parts and consumables are Category A requisition items
Doc #4 — Pharmaceutical and Medical Supply Management	Companion document for the pharmaceutical and logistics dimension of healthcare supply
Doc #156 — Skills Census	Medical device inventory and biomedical technician workforce census
Doc #33 — Tires	Rubber/elastomer supply chain affects gasket availability
Doc #65 — Hydroelectric Maintenance	Grid reliability determines whether electrically powered medical devices function
Doc #67 — Transpower Grid Operations	Stable power supply is a precondition for sensitive electronic medical equipment
Doc #88 — Spare Parts Triage and Cannibalisation	Medical devices are a subset of the national cannibalisation framework
Doc #89 — NZ Steel	Steel production for autoclave pressure vessels and instrument fabrication
Doc #91 — Machine Shop Operations	Fabrication of autoclave components, centrifuge rotors, and other mechanical medical device parts
Doc #94 — Welding Consumables	Pressure vessel fabrication and repair
Doc #116 — Pharmaceutical Rationing	Reagent and chemical supply for laboratory medicine; anaesthetic agent supply
Doc #116 — Surgical Consumable Conservation	Surgical capability depends on both consumable supplies (Doc #116) and functioning devices (this document)
Doc #119 — Local Pharmaceutical Production	Potential source of chemical sterilants, staining reagents, and anaesthetic agents
Doc #145 — Workforce Reallocation	Biomedical technicians are critical-skills personnel
Doc #150 — Treaty of Waitangi and Māori Governance	Governance framework for Crown-iwi interaction during recovery
Doc #157 — Trade Training	Biomedical technician training programme
Doc #160 — Heritage Skills Preservation	Institutional knowledge documentation for experienced biomedical technicians

---

RURAL ACCESS AND COMMUNITY-LEVEL MONITORING

Consolidation and rural access

The consolidation strategy in Section 3.3 concentrates medical technology at regional centres. This is the correct engineering decision for maximising fleet lifespan, but it increases travel distances for rural communities. The honest response is to address the access gap directly rather than pretend it can be wished away through different triage choices.

Mobile ultrasound circuits. Ultrasound is identified in Section 5.2 as NZ’s most durable long-term imaging modality. Mobile ultrasound units operated from a vehicle can serve rural communities on a scheduled circuit, extending diagnostic reach without permanent facility infrastructure. Feasibility depends on vehicle fuel allocation (Doc #6) and road condition, but the technical barrier is low: a portable ultrasound unit, a trained operator, and a vehicle.

Primary care provider networks as maintenance nodes. NZ’s primary care organisations — including kaupapa Māori health providers in rural and underserved areas — employ clinical staff with hands-on familiarity with the devices used in their settings. Including primary care provider staff in the biomedical technician training programme (Section 8) creates maintenance capacity embedded in communities rather than concentrated in urban centres.

Category 1 devices in rural settings. The Category 1 devices — manual microscopes, mechanical sphygmomanometers, surgical instruments, stethoscopes, autoclaves — can be maintained indefinitely with local skills and materials. Rural communities and community health services should be prioritised for stocking these durable devices and for training in their maintenance.

Community-based health monitoring

Certain clinical monitoring functions can be devolved to community and family networks with training and Category 1 equipment, reducing pressure on facility-based services. This approach has been demonstrated at scale in NZ’s community health provider networks.⁴⁵ The following devices are appropriate for community-based monitoring:

Device	Monitoring function	Training requirement	Maintenance
Mechanical aneroid sphygmomanometer	Blood pressure — hypertension monitoring and stroke/cardiac risk management	2–4 hours of instruction; technique validation	No consumables; annual calibration check by technician
Manual glucose meter (with reagent strips)	Blood glucose — diabetes management	2–4 hours of instruction	Reagent strip supply is finite (Category 2); priority allocation to diabetes patients
Pulse oximeter	Oxygen saturation — respiratory monitoring	1–2 hours of instruction	Battery-dependent (Category 2); conserve carefully
Stethoscope	Basic cardiac and respiratory auscultation	4–8 hours of instruction; regular review	No consumables

The practical limit on community monitoring is reagent supply (glucose strips) and battery supply (pulse oximeters). These are Category 2 constraints managed through the national spare parts triage framework (Doc #88), with priority allocation to high-need populations including diabetic patients managed through community-based monitoring.

---

FOOTNOTES

---

1. MRI superconducting magnets require continuous cooling to approximately 4 Kelvin (-269°C) using liquid helium. Modern MRI systems include cryocoolers (cold heads) that recondense helium vapour, reducing but not eliminating helium consumption. Cryocooler cold heads have a service life of approximately 15,000–25,000 hours (roughly 2–3 years of continuous operation) and require manufacturer-specific replacement parts. Without helium resupply or cryocooler maintenance, the magnet warms, loses superconductivity, and quenches — an irreversible event that typically requires a complete magnet recharge by the manufacturer. See: McRobbie DW, et al. “MRI from Picture to Proton.” Cambridge University Press, 3rd edition, 2017.↩︎

2. The NZ biomedical engineering and technology workforce is not comprehensively surveyed in publicly available sources. The estimate of 200–400 is based on typical staffing ratios for a healthcare system of NZ’s size (approximately 1 biomedical technician per 10,000–25,000 population is common in developed countries), adjusted for NZ’s reliance on manufacturer service contracts which reduces the need for in-house technicians. The actual figure should be established through the skills census (Doc #8). The Institute of Biomedical Engineering and Technology NZ (IBET NZ) may hold more precise membership data.↩︎

3. NZ government health capital expenditure data from Treasury and Ministry of Health annual reports. Medical device fleet replacement value is not reported as a single figure. The estimate of “several billion dollars” is based on the typical capital intensity of a healthcare system serving 5 million people, including imaging equipment (CT scanners at NZ$1–3 million each, MRI at NZ$2–5 million each), surgical equipment, laboratory analysers, and monitoring systems.↩︎

4. Pre-antiseptic surgical mortality: Nuland SB. “The Doctors’ Plague: Germs, Childbed Fever, and the Strange Story of Ignac Semmelweis.” W.W. Norton, 2003. Also: Wangensteen OH, Wangensteen SD. “The Rise of Surgery: From Empiric Craft to Scientific Discipline.” University of Minnesota Press, 1978. Surgical wound infection rates of 30–60% were common before Listerian antisepsis and autoclave sterilisation became standard in the late 19th century.↩︎

5. X-ray tube physics and failure modes: Bushberg JT, et al. “The Essential Physics of Medical Imaging.” Lippincott Williams & Wilkins, 4th edition, 2020. Chapter on X-ray production covers tube design, anode heat loading, focal spot degradation, and bearing failure in rotating-anode tubes. Tube life varies widely: a general diagnostic tube might last 50,000–200,000 exposures; a mammography tube or CT tube has different characteristics.↩︎

6. Ultrasound transducer physics: Szabo TL. “Diagnostic Ultrasound Imaging: Inside Out.” Academic Press, 2nd edition, 2014. Piezoelectric elements (typically PZT — lead zirconate titanate) degrade slowly through depoling and mechanical fatigue. Cable failure and connector degradation are more common failure modes than element failure in clinical ultrasound transducers.↩︎

7. Ventilator maintenance and failure modes: Moyle JTB, et al. “Ward’s Anaesthetic Equipment.” Elsevier, 6th edition, 2012. Modern ICU ventilators contain hundreds of electronic components. Older mechanical ventilators (e.g., Manley, Bird, Bennett) have far fewer failure modes and can be maintained with basic mechanical skills.↩︎

8. MRI superconducting magnets require continuous cooling to approximately 4 Kelvin (-269°C) using liquid helium. Modern MRI systems include cryocoolers (cold heads) that recondense helium vapour, reducing but not eliminating helium consumption. Cryocooler cold heads have a service life of approximately 15,000–25,000 hours (roughly 2–3 years of continuous operation) and require manufacturer-specific replacement parts. Without helium resupply or cryocooler maintenance, the magnet warms, loses superconductivity, and quenches — an irreversible event that typically requires a complete magnet recharge by the manufacturer. See: McRobbie DW, et al. “MRI from Picture to Proton.” Cambridge University Press, 3rd edition, 2017.↩︎

9. CT scanner X-ray tubes are rotating-anode tubes operating at much higher power levels than diagnostic X-ray tubes. They rotate at 7,000–10,000 RPM and must dissipate enormous thermal loads (up to several million heat units per scan). Tube life is typically 50,000–200,000 seconds of scanning time. See: Bushberg et al. (ref [^4]).↩︎

10. Modern automated laboratory analysers use proprietary reagent cartridges, calibrators, and controls manufactured by the analyser vendor. Most operate on a “razor and blades” business model — the analyser is sold or leased at or below cost, with revenue generated from reagent sales. The analysers are typically designed to reject third-party or expired reagents through electronic detection. When the supply of proprietary reagents is exhausted, the analyser cannot function. See: Plebani M. “Errors in clinical laboratories or errors in laboratory medicine?” Clinical Chemistry and Laboratory Medicine 44(6):750-759, 2006.↩︎

11. NZ medical imaging equipment data is not comprehensively published in a single public source. The OECD Health Statistics database reports NZ’s CT scanner density at approximately 9–10 per million population (approximately 45–50 scanners) and MRI at approximately 3 per million population (approximately 15 scanners). Conventional X-ray unit numbers are not reported in OECD data; the estimate of “several hundred” is based on the number of radiology-equipped facilities (public hospitals, private radiology practices, emergency departments, orthopaedic clinics, dental practices with OPG units). See: OECD Health Statistics, https://www.oecd.org/health/health-data.htm.↩︎

12. CT scanner X-ray tubes are rotating-anode tubes operating at much higher power levels than diagnostic X-ray tubes. They rotate at 7,000–10,000 RPM and must dissipate enormous thermal loads (up to several million heat units per scan). Tube life is typically 50,000–200,000 seconds of scanning time. See: Bushberg et al. (ref [^4]).↩︎

13. Ultrasound transducer physics: Szabo TL. “Diagnostic Ultrasound Imaging: Inside Out.” Academic Press, 2nd edition, 2014. Piezoelectric elements (typically PZT — lead zirconate titanate) degrade slowly through depoling and mechanical fatigue. Cable failure and connector degradation are more common failure modes than element failure in clinical ultrasound transducers.↩︎

14. Pre-antiseptic surgical mortality: Nuland SB. “The Doctors’ Plague: Germs, Childbed Fever, and the Strange Story of Ignac Semmelweis.” W.W. Norton, 2003. Also: Wangensteen OH, Wangensteen SD. “The Rise of Surgery: From Empiric Craft to Scientific Discipline.” University of Minnesota Press, 1978. Surgical wound infection rates of 30–60% were common before Listerian antisepsis and autoclave sterilisation became standard in the late 19th century.↩︎

15. NZ hospital sterilisation services are managed through Central Sterile Services Departments (CSSDs) at each public hospital. The exact number of autoclaves nationally is not published; the estimate of “several hundred” accounts for large CSSDs (multiple large autoclaves), smaller hospital units, and benchtop autoclaves in primary care, dental, and veterinary settings. Manufacturers with significant NZ installed base include Getinge (Sweden), Steris (US/Europe), Belimed (Switzerland), and Tuttnauer (Israel).↩︎

16. Steam sterilisation parameters: standard sterilisation cycles are 134°C at 2.1 bar absolute (approximately 1.1 bar gauge) for 3–18 minutes, or 121°C at 1.0 bar gauge for 15–30 minutes. These parameters are specified in AS/NZS 4187:2014 (Reprocessing of reusable medical devices in health service organisations) and equivalent international standards (EN 285, ISO 17665).↩︎

17. Autoclave gasket replacement intervals vary with usage intensity, temperature, and gasket material. High-usage CSSDs may replace door gaskets every 3–6 months; lower-usage benchtop units may get 12–24 months. Silicone gaskets generally outlast EPDM at autoclave temperatures. See: manufacturer maintenance manuals (Getinge, Steris, Tuttnauer).↩︎

18. NZ regional water hardness data from local council water quality reports. Canterbury (Christchurch and surrounds) and Hawke’s Bay generally have harder water (higher calcium and magnesium content) than the west coast of the South Island or volcanic regions of the central North Island. Hard water accelerates scale formation in boilers and steam generators.↩︎

19. Biological indicators (Bacillus stearothermophilus spore strips or vials) are the gold standard for sterilisation verification, demonstrating that actual biological kill has occurred. Chemical indicators (colour-change tape, Bowie-Dick test packs) demonstrate that temperature and steam penetration conditions were achieved but do not directly prove biological kill. When biological indicators are exhausted, thermocouple validation — placing calibrated temperature probes in test loads and demonstrating that sterilisation temperature was maintained for the required duration — provides physics-based assurance that sterilisation conditions were met. See: AS/NZS 4187:2014.↩︎

20. NZ industrial seal and gasket supply is distributed across multiple suppliers including Sealing Solutions NZ, James Walker NZ, Parker Hannifin NZ, and numerous industrial distributors. Total in-country stock of silicone and EPDM material is commercially sensitive and not publicly reported. The estimate of “tens of tonnes” is a rough approximation based on NZ’s industrial base size.↩︎

21. Boiling (100°C, atmospheric pressure) kills vegetative bacteria and most viruses but does not reliably kill bacterial endospores (particularly Clostridium and Bacillus species). Sterilisation requires temperatures above 100°C under pressure (autoclave) or prolonged dry heat above 160°C. See: Block SS. “Disinfection, Sterilization, and Preservation.” Lippincott Williams & Wilkins, 5th edition, 2001.↩︎

22. Peracetic acid (CH3CO3H) is produced by reacting acetic acid with hydrogen peroxide, typically with a sulfuric acid catalyst. Acetic acid can be produced by fermentation (vinegar production — well within NZ capability). Hydrogen peroxide production is more complex, requiring either the anthraquinone process (industrial chemistry) or electrochemical production (feasible with NZ’s electrical grid). See: McDonnell G, Russell AD. “Antiseptics and Disinfectants: Activity, Action, and Resistance.” Clinical Microbiology Reviews 12(1):147-179, 1999.↩︎

23. X-ray tube physics and failure modes: Bushberg JT, et al. “The Essential Physics of Medical Imaging.” Lippincott Williams & Wilkins, 4th edition, 2020. Chapter on X-ray production covers tube design, anode heat loading, focal spot degradation, and bearing failure in rotating-anode tubes. Tube life varies widely: a general diagnostic tube might last 50,000–200,000 exposures; a mammography tube or CT tube has different characteristics.↩︎

24. Medical Radiation Technologists Board (MRTB) NZ workforce data. https://www.mrtboard.org.nz/ — NZ has approximately 2,000–3,000 registered medical radiation technologists, including diagnostic radiographers, radiation therapists, and nuclear medicine technologists. The diagnostic radiographer workforce is the relevant group for X-ray and CT operation.↩︎

25. NZ medical imaging equipment data is not comprehensively published in a single public source. The OECD Health Statistics database reports NZ’s CT scanner density at approximately 9–10 per million population (approximately 45–50 scanners) and MRI at approximately 3 per million population (approximately 15 scanners). Conventional X-ray unit numbers are not reported in OECD data; the estimate of “several hundred” is based on the number of radiology-equipped facilities (public hospitals, private radiology practices, emergency departments, orthopaedic clinics, dental practices with OPG units). See: OECD Health Statistics, https://www.oecd.org/health/health-data.htm.↩︎

26. Ultrasound transducer physics: Szabo TL. “Diagnostic Ultrasound Imaging: Inside Out.” Academic Press, 2nd edition, 2014. Piezoelectric elements (typically PZT — lead zirconate titanate) degrade slowly through depoling and mechanical fatigue. Cable failure and connector degradation are more common failure modes than element failure in clinical ultrasound transducers.↩︎

27. Ultrasound coupling gel alternatives: Pringer S, Gaisl T, et al. “Comparison of ultrasound coupling media.” Journal of Diagnostic Medical Sonography, various editions. Commercial ultrasound gel is a water-based polymer gel (typically carbomer/carbopol based). Adequate coupling can be achieved with glycerin-water mixtures, aloe vera gel, or other water-based gels. The key requirement is acoustic impedance matching and absence of air bubbles at the transducer-skin interface.↩︎

28. Lithium-ion battery degradation: Barr’e A, et al. “A review on lithium-ion battery ageing mechanisms and estimations for automotive applications.” Journal of Power Sources 241:680-689, 2013. Typical lithium-ion cells retain 80% capacity after 300–500 full charge-discharge cycles. Calendar ageing (capacity loss in storage) occurs at approximately 2–5% per year depending on state of charge and temperature.↩︎

29. NZ lithium-ion battery stock estimate is based on device ownership data: approximately 5 million smartphones, 2–3 million laptops and tablets, and several hundred thousand power tools and e-bikes in NZ as of 2024. Each contains one or more lithium-ion cells with usable capacity. Consumer device battery capacities range from approximately 10–15 Wh (smartphones) to 50–100 Wh (laptops) to 200–700 Wh (power tools and e-bikes). The aggregate energy capacity is significant but harvesting, testing, and matching cells for medical device repurposing requires skilled labour and test equipment. See: NZ Telecommunications Forum device ownership surveys; Ministry for the Environment e-waste reporting.↩︎

30. NZ hospitals, universities, and secondary schools collectively hold thousands of optical microscopes. Teaching institutions alone (medical schools at Auckland and Otago, polytechnics, secondary schools with biology programmes) hold many hundreds. Hospital pathology laboratories hold clinical-grade instruments. The total is not precisely enumerated but is large.↩︎

31. Microbiological staining reagents: Crystal violet (the primary stain in Gram staining) is a triarylmethane dye historically derived from coal tar chemistry. Iodine (the mordant in Gram staining) can be extracted from kelp — NZ has abundant macroalgae resources (Doc #158). Safranin (the counterstain) is also a coal tar derivative. Acid-fast staining (Ziehl-Neelsen method) requires carbol fuchsin (basic fuchsin in phenol) and methylene blue — both synthetic dyes requiring organic chemistry capability. See: Madigan MT, et al. “Brock’s Biology of Microorganisms.” Pearson, various editions.↩︎

32. Hand-cranked centrifuge performance: the Hettich hand centrifuge and similar designs achieve approximately 2,000–3,000 relative centrifugal force (RCF/g) with sustained cranking. Clinical electric centrifuges typically operate at 3,000–5,000 g for routine separations (haematocrit, serum preparation) and up to 10,000–15,000 g for specialised applications. Sustained hand-cranking beyond 3–5 minutes is physically demanding. See: Bhamla MS, et al. “Hand-powered ultralow-cost paper centrifuge.” Nature Biomedical Engineering 1:0009, 2017; also WHO laboratory equipment guidelines for resource-limited settings.↩︎

33. Modern automated laboratory analysers use proprietary reagent cartridges, calibrators, and controls manufactured by the analyser vendor. Most operate on a “razor and blades” business model — the analyser is sold or leased at or below cost, with revenue generated from reagent sales. The analysers are typically designed to reject third-party or expired reagents through electronic detection. When the supply of proprietary reagents is exhausted, the analyser cannot function. See: Plebani M. “Errors in clinical laboratories or errors in laboratory medicine?” Clinical Chemistry and Laboratory Medicine 44(6):750-759, 2006.↩︎

34. NZ university science departments and hospital pathology laboratories collectively hold spectrophotometers across multiple generations of instrument. The estimate of “several hundred” is based on the number of clinical biochemistry and haematology laboratories (approximately 20–30 across public hospitals) plus university teaching and research laboratories (8 universities and multiple polytechnics). The actual number should be established through the asset census (Doc #8). UV-visible spectrophotometers from manufacturers including Shimadzu, Thermo Fisher, and Hitachi are common in NZ laboratories.↩︎

35. NZ ventilator numbers expanded significantly during the COVID-19 pandemic. Pre-pandemic, NZ had approximately 500–600 ventilators across ICU and anaesthetic settings. Additional ventilators were procured during 2020–2021. The exact current number should be established through the asset census. See: Ministry of Health COVID-19 response documentation and media reporting from 2020.↩︎

36. Galvanic oxygen sensors in ventilators and anaesthesia machines have a fixed electrochemical lifespan — typically 12–36 months regardless of usage — because the electrochemical cell is consumed by the sensing reaction. Replacement sensors are imported and finite. Paramagnetic oxygen analysers are an alternative technology with longer lifespans but are more complex and expensive. See: Ehrenwerth J, et al. “Anesthesia Equipment: Principles and Applications.” Elsevier, 2nd edition, 2013.↩︎

37. The Manley ventilator, developed by Roger Manley in the 1960s, is a gas-driven mechanical ventilator that requires no electrical power — it is driven by the pressure of the anaesthetic gas supply. Variants were widely used in the UK, NZ, and other Commonwealth countries. Any surviving units in NZ are functionally irreplaceable under post-event conditions. See: Mushin WW, et al. “Automatic Ventilation of the Lungs.” Blackwell Scientific, 3rd edition, 1980.↩︎

38. Fisher & Paykel Healthcare (FPH) is a NZ-headquartered medical device company listed on the NZX and ASX. Its manufacturing facility in East Tamaki, Auckland, produces respiratory humidification systems, CPAP/BiPAP devices for sleep apnea, nasal high-flow therapy systems, and related respiratory products. FPH is one of very few medical device manufacturers with significant NZ-based production. https://www.fphcare.com/↩︎

39. Diethyl ether synthesis from ethanol requires dehydration using sulfuric acid as a catalyst at approximately 140°C. The process is well-described in organic chemistry literature and was performed on an industrial scale in the 19th and early 20th centuries. NZ can produce ethanol from fermentation (Doc #113). Sulfuric acid production is covered in Doc #113 (if it exists) or would be needed from existing NZ industrial stocks. Ether is highly flammable — this is its primary safety hazard as an anaesthetic agent. See: Crawford JS. “Principles and Practice of Obstetric Anaesthesia.” Blackwell Scientific, various editions.↩︎

40. Ether anaesthesia performance comparison: diethyl ether induction time is typically 5–15 minutes (compared to 1–2 minutes for sevoflurane); post-operative nausea and vomiting rates with ether are approximately 50–80% versus 20–30% with modern agents; ether is flammable in air at concentrations above approximately 1.9% by volume, requiring elimination of all ignition sources including electrocautery. See: Maltby JR. “Notable Names in Anaesthesia.” Royal Society of Medicine Press, 2002; Dorsch JA, Dorsch SE. “Understanding Anesthesia Equipment.” Lippincott Williams & Wilkins, 5th edition, 2008.↩︎

41. Draw-over anaesthesia systems: Dobson MB. “Anaesthesia at the District Hospital.” WHO, 2nd edition, 2000. The Oxford Miniature Vaporiser (OMV) and Epstein-Macintosh-Oxford (EMO) vaporiser are designed for use without compressed gas supplies or electrical power. They are standard equipment in military field hospitals and developing-world anaesthesia. The engineering is relatively straightforward — a temperature-compensated wick vaporiser with calibrated output — and fabrication is within NZ’s metalworking capability if technical drawings are available.↩︎

42. Draw-over anaesthesia systems: Dobson MB. “Anaesthesia at the District Hospital.” WHO, 2nd edition, 2000. The Oxford Miniature Vaporiser (OMV) and Epstein-Macintosh-Oxford (EMO) vaporiser are designed for use without compressed gas supplies or electrical power. They are standard equipment in military field hospitals and developing-world anaesthesia. The engineering is relatively straightforward — a temperature-compensated wick vaporiser with calibrated output — and fabrication is within NZ’s metalworking capability if technical drawings are available.↩︎

43. Ketamine: WHO Model List of Essential Medicines includes ketamine as an essential anaesthetic. It provides dissociative anaesthesia (analgesia, amnesia, and sedation) without respiratory depression at standard doses. It can be administered IV or IM, does not require complex delivery equipment, and is stable in storage. Ketamine is manufactured as a simple organic molecule (2-(2-chlorophenyl)-2-(methylamino)cyclohexanone) — not a biologic — and has excellent shelf-life extension potential. See: Green SM, Roback MG, et al. “Clinical Practice Guideline for Emergency Department Ketamine Dissociative Sedation.” Annals of Emergency Medicine 57(5):449-461, 2011.↩︎

44. The NZ biomedical engineering and technology workforce is not comprehensively surveyed in publicly available sources. The estimate of 200–400 is based on typical staffing ratios for a healthcare system of NZ’s size (approximately 1 biomedical technician per 10,000–25,000 population is common in developed countries), adjusted for NZ’s reliance on manufacturer service contracts which reduces the need for in-house technicians. The actual figure should be established through the skills census (Doc #8). The Institute of Biomedical Engineering and Technology NZ (IBET NZ) may hold more precise membership data.↩︎

45. Whānau-based health monitoring in Māori health contexts: the model of engaging whānau as active participants in managing the health of family members with chronic conditions (diabetes, cardiovascular disease, respiratory disease) is a core feature of kaupapa Māori health practice and has been implemented through Māori health provider networks for several decades. See: Came H, et al. “Ngā Paiaka o te Hauora: The roots of health — a review of the evidence on Māori health gains from engaging with te ao Māori.” Health Promotion Forum of New Zealand, 2019. The extension of this model to include hands-on monitoring using simple clinical devices in the recovery context is a practical adaptation of an established approach, not a new untested intervention.↩︎